Bisphosphonates and RANK ligand inhibitors for the treatment and prevention of metastatic bone disease.
Neville-Webbe
H L
HL
Academic Department of Clinical Oncology, Weston Park Hospital, Sheffield S10 2SJ, UK. h.l.neville-webbe@sheffield.ac.uk
Coleman
R E
RE